CLRB Short Volume

Cellectar Biosciences, Inc. (CLRB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $8.3M, listed on NASDAQ, employing roughly 11 people, carrying a beta of 0.55 to the broader market. Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. Led by James V. Caruso, public since 2005-11-10.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-07-16
Short Volume
6.4K
Total Volume
22.3K
Short %
28.83%
30-Day Avg Short %
46.69%

Showing 30 days of FINRA short volume data for Cellectar Biosciences, Inc..

Learn how short volume is reported and how to read the data →

Frequently asked CLRB short volume questions

What is the daily CLRB short volume?
As of Jul 16, 2026, Cellectar Biosciences, Inc. (CLRB) short volume is 6.4K shares against 22.3K total reported volume, or 28.83% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is CLRB short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does CLRB short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.